PT81498B
(pt)
*
|
1984-11-23 |
1987-12-30 |
Schering Ag |
Processo para a preparacao de composicoes para diagnostico contendo particulas magneticas
|
US5512332A
(en)
*
|
1985-10-04 |
1996-04-30 |
Immunivest Corporation |
Process of making resuspendable coated magnetic particles
|
US5597531A
(en)
*
|
1985-10-04 |
1997-01-28 |
Immunivest Corporation |
Resuspendable coated magnetic particles and stable magnetic particle suspensions
|
US4795698A
(en)
*
|
1985-10-04 |
1989-01-03 |
Immunicon Corporation |
Magnetic-polymer particles
|
US5160726A
(en)
*
|
1990-02-15 |
1992-11-03 |
Advanced Magnetics Inc. |
Filter sterilization for production of colloidal, superparamagnetic MR contrast agents
|
US4951675A
(en)
*
|
1986-07-03 |
1990-08-28 |
Advanced Magnetics, Incorporated |
Biodegradable superparamagnetic metal oxides as contrast agents for MR imaging
|
US5102652A
(en)
*
|
1986-07-03 |
1992-04-07 |
Advanced Magnetics Inc. |
Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
|
US5248492A
(en)
*
|
1986-07-03 |
1993-09-28 |
Advanced Magnetics, Inc. |
Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
|
US5219554A
(en)
|
1986-07-03 |
1993-06-15 |
Advanced Magnetics, Inc. |
Hydrated biodegradable superparamagnetic metal oxides
|
US5262176A
(en)
*
|
1986-07-03 |
1993-11-16 |
Advanced Magnetics, Inc. |
Synthesis of polysaccharide covered superparamagnetic oxide colloids
|
DE3709851A1
(de)
*
|
1987-03-24 |
1988-10-06 |
Silica Gel Gmbh Adsorptions Te |
Nmr-diagnostische fluessigkeitszusammensetzungen
|
US6013531A
(en)
*
|
1987-10-26 |
2000-01-11 |
Dade International Inc. |
Method to use fluorescent magnetic polymer particles as markers in an immunoassay
|
US5395688A
(en)
*
|
1987-10-26 |
1995-03-07 |
Baxter Diagnostics Inc. |
Magnetically responsive fluorescent polymer particles
|
DE3852299T2
(de)
*
|
1987-10-26 |
1995-07-20 |
Baxter Diagnostics Inc |
Verfahren zur herstellung magnetisch empfindlicher polymerteilchen und deren anwendung.
|
DE3807904A1
(de)
*
|
1988-03-10 |
1989-09-21 |
Behringwerke Ag |
Magnetische protein-konjugate, verfahren zu ihrer herstellung und ihre verwendung
|
DE68911359T2
(de)
*
|
1988-04-26 |
1994-05-11 |
Nippon Telegraph & Telephone |
Lasermagnetisches Immuntestverfahren und Gerät dazu.
|
US5238811A
(en)
*
|
1988-04-26 |
1993-08-24 |
Nippon Telegraph And Telephone Corporation |
Laser magnetic immunoassay method and apparatus therefor and superparamagnetic material-labeled body and method for the manufacture of same
|
US5236824A
(en)
*
|
1988-04-26 |
1993-08-17 |
Nippon Telegraph And Telephone Corporation |
Laser magnetic immunoassay method and method by a magnetophoresis apparatus therefor
|
GB8813682D0
(en)
*
|
1988-06-09 |
1988-07-13 |
Reckitt & Colmann Prod Ltd |
Pharmaceutical compositions
|
US5145661A
(en)
*
|
1988-08-31 |
1992-09-08 |
Wayne State University |
Method and contrast agent for use in magnetic resonance imaging of abscess
|
US5108933A
(en)
*
|
1988-09-16 |
1992-04-28 |
Immunicon Corporation |
Manipulation of colloids for facilitating magnetic separations
|
ATE129075T1
(de)
*
|
1988-11-14 |
1995-10-15 |
Akzo Nobel Nv |
Wässerige suspension für diagnostischen test.
|
JPH02210262A
(ja)
*
|
1989-02-10 |
1990-08-21 |
Shinotesuto Kenkyusho:Kk |
間接凝集反応測定法
|
US5114703A
(en)
*
|
1989-05-30 |
1992-05-19 |
Alliance Pharmaceutical Corp. |
Percutaneous lymphography using particulate fluorocarbon emulsions
|
DE3919873A1
(de)
*
|
1989-06-19 |
1990-12-20 |
Behringwerke Ag |
Magnetische protein-konjugate, verfahren zu ihrer herstellung und ihre verwendung
|
US5178834A
(en)
*
|
1989-07-19 |
1993-01-12 |
Tosoh Corporation |
Automatic immunoassay analyzer
|
US5698271A
(en)
*
|
1989-08-22 |
1997-12-16 |
Immunivest Corporation |
Methods for the manufacture of magnetically responsive particles
|
FR2656317B1
(fr)
*
|
1989-12-27 |
1994-02-04 |
Rhone Poulenc Chimie |
Microspheres magnetisables a base de polysilsesquioxane, leur procede de preparation et leur application en biologie.
|
FR2656318B1
(fr)
*
|
1989-12-27 |
1994-02-04 |
Rhone Poulenc Chimie |
Microspheres "core-shell" magnetisables a base d'organopolysiloxane reticule, leur procede de preparation et leur application en biologie.
|
EP0514493B1
(de)
|
1990-02-15 |
1996-03-27 |
Advanced Magnetics Incorporated |
FILTERSTERILISATION ZUR HERSTELLUNG VON KOLLOIDALEN SUPERPARAMAGNETISCHEN MR-KONTRASTMITTELN und ihre Verwendung
|
GB9006977D0
(en)
*
|
1990-03-28 |
1990-05-23 |
Nycomed As |
Compositions
|
US5254460A
(en)
*
|
1990-05-03 |
1993-10-19 |
Advanced Magnetics, Inc. |
Solvent mediated relaxation assay system
|
US5164297A
(en)
*
|
1990-05-03 |
1992-11-17 |
Advanced Magnetics Inc. |
Solvent mediated relaxation assay system
|
US5240640A
(en)
*
|
1990-06-04 |
1993-08-31 |
Coulter Corporation |
In situ use of gelatin or an aminodextran in the preparation of uniform ferrite particles
|
IL98744A0
(en)
*
|
1990-07-06 |
1992-07-15 |
Gen Hospital Corp |
Method of studying biological tissue using monocrystalline particles
|
US5200084A
(en)
*
|
1990-09-26 |
1993-04-06 |
Immunicon Corporation |
Apparatus and methods for magnetic separation
|
US6013532A
(en)
*
|
1990-09-26 |
2000-01-11 |
Immunivest Corporation |
Methods for magnetic immobilization and manipulation of cells
|
US5622831A
(en)
*
|
1990-09-26 |
1997-04-22 |
Immunivest Corporation |
Methods and devices for manipulation of magnetically collected material
|
US5466609A
(en)
*
|
1990-10-31 |
1995-11-14 |
Coulter Corporation |
Biodegradable gelatin-aminodextran particle coatings of and processes for making same
|
US5639620A
(en)
*
|
1990-10-31 |
1997-06-17 |
Coulter Corporation |
Polymeric particles having a biodegradable gelatin or aminodextran coating and process for making same
|
US5169754A
(en)
*
|
1990-10-31 |
1992-12-08 |
Coulter Corporation |
Biodegradable particle coatings having a protein covalently immobilized by means of a crosslinking agent and processes for making same
|
AU652804B2
(en)
*
|
1991-01-19 |
1994-09-08 |
Meito Sangyo Kabushiki Kaisha |
Composition containing ultrafine particles of magnetic metal oxide
|
US5370901A
(en)
*
|
1991-02-15 |
1994-12-06 |
Bracco International B.V. |
Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
|
US5242833A
(en)
*
|
1991-03-20 |
1993-09-07 |
Reference Diagnostics, Inc. |
Lipid fractionation
|
US5646001A
(en)
*
|
1991-03-25 |
1997-07-08 |
Immunivest Corporation |
Affinity-binding separation and release of one or more selected subset of biological entities from a mixed population thereof
|
US5795470A
(en)
*
|
1991-03-25 |
1998-08-18 |
Immunivest Corporation |
Magnetic separation apparatus
|
US5186827A
(en)
*
|
1991-03-25 |
1993-02-16 |
Immunicon Corporation |
Apparatus for magnetic separation featuring external magnetic means
|
US5466574A
(en)
*
|
1991-03-25 |
1995-11-14 |
Immunivest Corporation |
Apparatus and methods for magnetic separation featuring external magnetic means
|
AU660013B2
(en)
*
|
1991-03-27 |
1995-06-08 |
Nycomed Salutar, Inc. |
Contrast media
|
CA2065719A1
(en)
|
1991-04-30 |
1992-10-31 |
John B. Findlay |
Nucleic acid amplification and detection methods using rapid polymerase chain reaction cycle
|
IT1252145B
(it)
*
|
1991-11-29 |
1995-06-05 |
Bracco Ind Chimica Spa |
Metodo e formulazioni adatte a migliorare lo studio degli organi cavi nell'uomo
|
US5225282A
(en)
*
|
1991-12-13 |
1993-07-06 |
Molecular Bioquest, Inc. |
Biodegradable magnetic microcluster comprising non-magnetic metal or metal oxide particles coated with a functionalized polymer
|
US5248772A
(en)
*
|
1992-01-29 |
1993-09-28 |
Coulter Corporation |
Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents
|
GB2265004B
(en)
*
|
1992-03-10 |
1996-01-10 |
Univ Cardiff |
Immuno-agglutination assay using ultrasonic standing wave field
|
US5334471A
(en)
*
|
1992-07-02 |
1994-08-02 |
Xerox Corporation |
Low gloss encapsulated compositions
|
WO1994009368A1
(en)
*
|
1992-10-15 |
1994-04-28 |
Coulter Corporation |
Particles having gelatin-aminodextran coatings of and processes for making same
|
US5349957A
(en)
*
|
1992-12-02 |
1994-09-27 |
Sterling Winthrop Inc. |
Preparation and magnetic properties of very small magnetite-dextran particles
|
US5855790A
(en)
*
|
1994-02-07 |
1999-01-05 |
Selective Environmental Technologies, Inc. |
Magnetic particles, a method for the preparation thereof and their use in the purification of solutions
|
JPH10502494A
(ja)
*
|
1994-07-07 |
1998-03-03 |
チロン ダイアグノスティクス コーポレーション |
高分散性の磁性金属酸化物、その製造方法および使用
|
US5871625A
(en)
|
1994-08-25 |
1999-02-16 |
University Of Iowa Research Foundation |
Magnetic composites for improved electrolysis
|
US6001248A
(en)
|
1994-08-25 |
1999-12-14 |
The University Of Iowa Research Foundation |
Gradient interface magnetic composites and systems therefor
|
US5622822A
(en)
|
1994-09-13 |
1997-04-22 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Methods for capture and selective release of nucleic acids using polyethyleneimine and an anionic phosphate ester surfactant and amplification of same
|
US5705366A
(en)
|
1994-09-15 |
1998-01-06 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Coamplification of target nucleic acids using volume exclusion agent in reaction composition, test kit and test device useful therefor
|
US5582988A
(en)
|
1994-09-15 |
1996-12-10 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Methods for capture and selective release of nucleic acids using weakly basic polymer and amplification of same
|
US5693784A
(en)
*
|
1994-09-19 |
1997-12-02 |
Promega Corporation |
Methods for creating agglomerates from colloidal particles
|
US5750339A
(en)
*
|
1994-11-30 |
1998-05-12 |
Thomas Jefferson University |
Methods for identifying fetal cells
|
EP0873358A2
(de)
*
|
1995-01-13 |
1998-10-28 |
Innogenetics N.V. |
Einfangen von mikroorganismen mittels komplement komponenten
|
US5705059A
(en)
*
|
1995-02-27 |
1998-01-06 |
Miltenyi; Stefan |
Magnetic separation apparatus
|
US5741714A
(en)
*
|
1995-07-18 |
1998-04-21 |
Immunivest Corporation |
Detection of bound analyte by magnetic partitioning and masking
|
US5660990A
(en)
*
|
1995-08-18 |
1997-08-26 |
Immunivest Corporation |
Surface immobilization of magnetically collected materials
|
CN1212629A
(zh)
|
1996-01-10 |
1999-03-31 |
耐克麦德英梅金公司 |
造影剂
|
GB9600427D0
(en)
*
|
1996-01-10 |
1996-03-13 |
Nycomed Imaging As |
Contrast media
|
DE19606598C1
(de)
*
|
1996-02-22 |
1997-11-13 |
Innova Gmbh |
Magnetpartikel mit biologisch aktiven Rezeptoren sowie Herstellung und Verwendung
|
US6251691B1
(en)
|
1996-04-25 |
2001-06-26 |
Bioarray Solutions, Llc |
Light-controlled electrokinetic assembly of particles near surfaces
|
FR2758884B1
(fr)
|
1997-01-30 |
1999-04-02 |
Bio Merieux |
Procede pour isoler, notamment detecter ou quantifier un analyte dans un milieu
|
FR2762394B1
(fr)
*
|
1997-04-16 |
1999-05-28 |
Bio Merieux |
Compose ligand de coordination et utilisation pour fixer un materiel biologique
|
US6372517B1
(en)
|
1997-06-18 |
2002-04-16 |
Innova-Gesellschaft Zur Entwicklung Und Vermarktung Innovativer Produkte M.B.H. |
Magnetic particles with biologically active receptors
|
US6241894B1
(en)
*
|
1997-10-10 |
2001-06-05 |
Systemix |
High gradient magnetic device and method for cell separation or purification
|
US6337215B1
(en)
|
1997-12-01 |
2002-01-08 |
International Business Machines Corporation |
Magnetic particles having two antiparallel ferromagnetic layers and attached affinity recognition molecules
|
CA2320418C
(en)
*
|
1998-02-12 |
2008-06-17 |
Leon W.M.M. Terstappen |
Methods and reagents for the rapid and efficient isolation of circulating cancer cells
|
US20010018192A1
(en)
*
|
1998-02-12 |
2001-08-30 |
Terstappen Leon W.M.M. |
Labeled cells for use as an internal functional control in rare cell detection assays
|
US7282350B2
(en)
|
1998-02-12 |
2007-10-16 |
Immunivest Corporation |
Labeled cell sets for use as functional controls in rare cell detection assays
|
US6908770B1
(en)
|
1998-07-16 |
2005-06-21 |
Board Of Regents, The University Of Texas System |
Fluid based analysis of multiple analytes by a sensor array
|
US6368866B1
(en)
|
1998-08-03 |
2002-04-09 |
Reference Diagnostics, Inc. |
Rapid separation assay for total iron binding capacity
|
US6361749B1
(en)
|
1998-08-18 |
2002-03-26 |
Immunivest Corporation |
Apparatus and methods for magnetic separation
|
US6551843B1
(en)
|
1999-01-29 |
2003-04-22 |
Immunivest Corporation |
Methods for enhancing binding interactions between members of specific binding pairs
|
AU4228200A
(en)
|
1999-04-09 |
2000-11-14 |
Shot, Inc. |
Multistage electromagnetic separator for purifying cells, chemicals and protein structures
|
US20040058401A1
(en)
*
|
1999-04-13 |
2004-03-25 |
Blaise Bossy |
Method for detecting rare event
|
JP4643023B2
(ja)
*
|
1999-05-04 |
2011-03-02 |
オルソ−クリニカル ダイアグノスティクス,インコーポレイティド |
細胞溶解剤を使用せずに試料からdnaを迅速に効率よく捕捉する方法
|
US6623982B1
(en)
*
|
1999-07-12 |
2003-09-23 |
Immunivest Corporation |
Increased separation efficiency via controlled aggregation of magnetic nanoparticles
|
WO2001006253A2
(en)
|
1999-07-16 |
2001-01-25 |
Board Of Regents, The University Of Texas System |
Detection system based on an analyte reactive particle
|
US7022517B1
(en)
|
1999-07-16 |
2006-04-04 |
Board Of Regents, The University Of Texas System |
Method and apparatus for the delivery of samples to a chemical sensor array
|
AU2001236597A1
(en)
*
|
2000-01-31 |
2001-08-07 |
Board Of Regents, The University Of Texas System |
System and method for the analysis of bodily fluids
|
US7262006B1
(en)
|
2000-05-01 |
2007-08-28 |
Ortho-Clinical Diagnostics, Inc. |
Rapid and efficient capture of DNA from sample without using cell lysing reagent
|
US9709559B2
(en)
|
2000-06-21 |
2017-07-18 |
Bioarray Solutions, Ltd. |
Multianalyte molecular analysis using application-specific random particle arrays
|
DE60117556T2
(de)
*
|
2000-06-21 |
2006-11-02 |
Bioarray Solutions Ltd. |
Multianalytische molekularanalyse durch verwendung anwendungsspezifischer zufallspartikelarrays
|
US7169618B2
(en)
|
2000-06-28 |
2007-01-30 |
Skold Technology |
Magnetic particles and methods of producing coated magnetic particles
|
EP1312671B1
(de)
|
2000-08-21 |
2009-04-01 |
National Institute of Advanced Industrial Science and Technology |
Magnetische partikel mit kritischer lösungstemperatur am unteren bereich
|
GB2368909B
(en)
*
|
2000-11-09 |
2004-09-22 |
Amersham Pharm Biotech Uk Ltd |
Separation particles
|
US6649419B1
(en)
*
|
2000-11-28 |
2003-11-18 |
Large Scale Proteomics Corp. |
Method and apparatus for protein manipulation
|
US20020160363A1
(en)
*
|
2001-01-31 |
2002-10-31 |
Mcdevitt John T. |
Magnetic-based placement and retention of sensor elements in a sensor array
|
EP1373874A4
(de)
*
|
2001-01-31 |
2004-03-31 |
Univ Texas |
Verfahren und vorrichtung zum eingrenzen von materialien in einem mikrobearbeiteten chemischen sensorarray
|
US20030003436A1
(en)
*
|
2001-02-05 |
2003-01-02 |
Willson C. Grant |
Use of mesoscale self-assembly and recognition to effect delivery of sensing reagent for arrayed sensors
|
US7262063B2
(en)
|
2001-06-21 |
2007-08-28 |
Bio Array Solutions, Ltd. |
Directed assembly of functional heterostructures
|
FR2826592B1
(fr)
|
2001-06-27 |
2003-08-15 |
Bio Merieux |
Procede, dispositif, et equipement de separation par voie humide de micro particules magnetiques
|
US7863012B2
(en)
*
|
2004-02-17 |
2011-01-04 |
Veridex, Llc |
Analysis of circulating tumor cells, fragments, and debris
|
US20040106109A1
(en)
*
|
2001-10-02 |
2004-06-03 |
Belly Robert T |
Detection of ras mutations
|
NZ532947A
(en)
|
2001-10-15 |
2006-01-27 |
Bioarray Solutions Ltd |
Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection
|
US7018849B2
(en)
*
|
2002-01-15 |
2006-03-28 |
Piasio Roger N |
Process for (A) separating biological/ligands from dilute solutions and (B) conducting an immunochromatographic assay thereof employing superparamagnetic particles throughtout
|
US6792019B2
(en)
*
|
2002-02-28 |
2004-09-14 |
Texas Instruments Incorporated |
Driver with tail currents in discrete subranges
|
US7214427B2
(en)
*
|
2002-03-21 |
2007-05-08 |
Aviva Biosciences Corporation |
Composite beads comprising magnetizable substance and electro-conductive substance
|
JP2005522679A
(ja)
*
|
2002-04-12 |
2005-07-28 |
インストゥルメンテイション ラボラトリー カンパニー |
イムノアッセイプローブ
|
CA2523626A1
(en)
|
2002-04-26 |
2003-11-06 |
Board Of Regents, The University Of Texas System |
Method and system for the detection of cardiac risk factors
|
EP1521589A4
(de)
*
|
2002-05-07 |
2008-06-04 |
Univ California |
Bioaktivation von partikeln
|
US20040229380A1
(en)
*
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
ErbB heterodimers as biomarkers
|
EP2107120A1
(de)
*
|
2002-07-24 |
2009-10-07 |
Board of Regents, The University of Texas System |
Erfassung und Detektion von Mikroben mittels Membranverfahren
|
AU2003298655A1
(en)
|
2002-11-15 |
2004-06-15 |
Bioarray Solutions, Ltd. |
Analysis, secure access to, and transmission of array images
|
US20040109824A1
(en)
*
|
2002-12-06 |
2004-06-10 |
Hinds Kathleen Allison |
Particles for imaging cells
|
US7255895B2
(en)
*
|
2003-01-21 |
2007-08-14 |
Bioarray Solutions, Ltd. |
Method for controlling solute loading of polymer microparticles
|
US6964747B2
(en)
*
|
2003-01-21 |
2005-11-15 |
Bioarray Solutions, Ltd. |
Production of dyed polymer microparticles
|
US6873241B1
(en)
|
2003-03-24 |
2005-03-29 |
Robert O. Sanchez |
High frequency transformers and high Q factor inductors formed using epoxy-based magnetic polymer materials
|
WO2004087018A2
(en)
|
2003-03-28 |
2004-10-14 |
Ev3 Inc. |
Double ended intravascular medical device
|
CA2521077A1
(en)
|
2003-04-01 |
2004-10-28 |
Monogram Biosciences, Inc. |
Erbb surface receptor complexes as biomarkers
|
WO2004097371A2
(en)
*
|
2003-04-25 |
2004-11-11 |
Board Of Regents, The University Of Texas System |
System and method for the detection of analytes
|
WO2004104922A2
(en)
*
|
2003-05-16 |
2004-12-02 |
Board Of Regents, The University Of Texas System |
Image and part recognition technology
|
US9317922B2
(en)
|
2003-05-16 |
2016-04-19 |
Board Of Regents The University Of Texas System |
Image and part recognition technology
|
AR047692A1
(es)
*
|
2003-07-10 |
2006-02-08 |
Epix Medical Inc |
Imagenes de blancos estacionarios
|
US7402398B2
(en)
*
|
2003-07-17 |
2008-07-22 |
Monogram Biosciences, Inc. |
Measuring receptor homodimerization
|
JP4996248B2
(ja)
|
2003-07-31 |
2012-08-08 |
ハンディーラブ インコーポレイテッド |
粒子含有サンプルの処理
|
AU2004267420A1
(en)
*
|
2003-08-11 |
2005-03-03 |
Monogram Biosciences, Inc. |
Detecting and profiling molecular complexes
|
WO2005029705A2
(en)
*
|
2003-09-18 |
2005-03-31 |
Bioarray Solutions, Ltd. |
Number coding for identification of subtypes of coded types of solid phase carriers
|
ATE532066T1
(de)
*
|
2003-09-22 |
2011-11-15 |
Bioarray Solutions Ltd |
Oberflächenimmobilisierter polyelektrolyt mit mehreren, zur kovalenten bindung an biomoleküle fähigen funktionellen gruppen
|
WO2005045059A2
(en)
*
|
2003-10-28 |
2005-05-19 |
Bioarray Solutions Ltd. |
Allele assignment and probe selection in multiplexed assays of polymorphic targets
|
WO2005042763A2
(en)
*
|
2003-10-28 |
2005-05-12 |
Bioarray Solutions Ltd. |
Optimization of gene expression analysis using immobilized capture probes
|
EP1694859B1
(de)
|
2003-10-29 |
2015-01-07 |
Bioarray Solutions Ltd |
Multiplex-nukleinsäureanalyse mittels fragmentierung doppelsträngiger dna
|
AU2003285133A1
(en)
*
|
2003-11-05 |
2005-06-24 |
The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services |
Biofunctionalized quantum dots for biological imaging
|
US20050106576A1
(en)
*
|
2003-11-17 |
2005-05-19 |
Hashem Akhavan-Tafti |
Methods of using cleavable solid phases for isolating nucleic acids
|
US20050106577A1
(en)
*
|
2003-11-17 |
2005-05-19 |
Hashem Akhavan-Tafti |
Cleavable solid phases for isolating nucleic acids
|
AU2004237844B2
(en)
|
2003-12-23 |
2011-01-27 |
Therakos, Inc. |
Extracorporeal photopheresis in combination with anti-TNF treatment
|
US20050181353A1
(en)
*
|
2004-02-17 |
2005-08-18 |
Rao Galla C. |
Stabilization of cells and biological specimens for analysis
|
US20060257991A1
(en)
*
|
2004-02-27 |
2006-11-16 |
Mcdevitt John T |
Integration of fluids and reagents into self-contained cartridges containing particle-based sensor elements and membrane-based sensor elements
|
US8101431B2
(en)
*
|
2004-02-27 |
2012-01-24 |
Board Of Regents, The University Of Texas System |
Integration of fluids and reagents into self-contained cartridges containing sensor elements and reagent delivery systems
|
US7781226B2
(en)
*
|
2004-02-27 |
2010-08-24 |
The Board Of Regents Of The University Of Texas System |
Particle on membrane assay system
|
US8105849B2
(en)
*
|
2004-02-27 |
2012-01-31 |
Board Of Regents, The University Of Texas System |
Integration of fluids and reagents into self-contained cartridges containing sensor elements
|
US20060257854A1
(en)
*
|
2004-02-27 |
2006-11-16 |
Mcdevitt John T |
Membrane assay system including preloaded particles
|
US8852862B2
(en)
|
2004-05-03 |
2014-10-07 |
Handylab, Inc. |
Method for processing polynucleotide-containing samples
|
US8211386B2
(en)
*
|
2004-06-08 |
2012-07-03 |
Biokit, S.A. |
Tapered cuvette and method of collecting magnetic particles
|
WO2006093516A2
(en)
|
2004-06-22 |
2006-09-08 |
The Regents Of The University Of California |
Peptide-coated nanoparticles with graded shell compositions
|
US7363170B2
(en)
*
|
2004-07-09 |
2008-04-22 |
Bio Array Solutions Ltd. |
Transfusion registry network providing real-time interaction between users and providers of genetically characterized blood products
|
US7848889B2
(en)
|
2004-08-02 |
2010-12-07 |
Bioarray Solutions, Ltd. |
Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
|
CA2587085C
(en)
|
2004-10-27 |
2017-08-08 |
Cepheid |
Closed-system multi-stage nucleic acid amplification reactions
|
US7939267B2
(en)
*
|
2004-11-04 |
2011-05-10 |
Laboratory Corporation Of America Holdings |
Detection of activation of endothelial cells as surrogate marker for angiogenesis
|
TWI277632B
(en)
*
|
2004-12-14 |
2007-04-01 |
Nat Univ Chung Cheng |
Magnetic polymer microbeads and a method for preparing the same
|
WO2006112771A1
(en)
*
|
2005-04-18 |
2006-10-26 |
Ge Healthcare Bio-Sciences Ab |
Magnetic beads
|
US7300631B2
(en)
*
|
2005-05-02 |
2007-11-27 |
Bioscale, Inc. |
Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles
|
US7648844B2
(en)
*
|
2005-05-02 |
2010-01-19 |
Bioscale, Inc. |
Method and apparatus for detection of analyte using an acoustic device
|
US7611908B2
(en)
*
|
2005-05-02 |
2009-11-03 |
Bioscale, Inc. |
Method and apparatus for therapeutic drug monitoring using an acoustic device
|
US7749445B2
(en)
*
|
2005-05-02 |
2010-07-06 |
Bioscale, Inc. |
Method and apparatus for analyzing bioprocess fluids
|
CA2610793A1
(en)
|
2005-05-31 |
2007-05-10 |
Labnow, Inc. |
Methods and compositions related to determination and use of white blood cell counts
|
US8486629B2
(en)
|
2005-06-01 |
2013-07-16 |
Bioarray Solutions, Ltd. |
Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation
|
CN1700015B
(zh)
*
|
2005-06-20 |
2010-10-06 |
张爱华 |
组件式多功能传感器件
|
CA2613078A1
(en)
*
|
2005-06-24 |
2007-01-04 |
Board Of Regents, The University Of Texas System |
Systems and methods including self-contained cartridges with detection systems and fluid delivery systems
|
WO2007005666A2
(en)
*
|
2005-07-01 |
2007-01-11 |
Board Of Regents, The University Of Texas System |
System and method of analyte detection using differential receptors
|
US7901950B2
(en)
*
|
2005-08-12 |
2011-03-08 |
Veridex, Llc |
Method for assessing disease states by profile analysis of isolated circulating endothelial cells
|
CN101351118B
(zh)
*
|
2005-11-02 |
2015-05-27 |
特拉科斯有限公司 |
凋亡细胞在离体产生调节t细胞中的应用
|
DE102005058979A1
(de)
*
|
2005-12-09 |
2007-06-21 |
Qiagen Gmbh |
Magnetische Polymerpartikel
|
US10900066B2
(en)
|
2006-03-24 |
2021-01-26 |
Handylab, Inc. |
Microfluidic system for amplifying and detecting polynucleotides in parallel
|
ES2692380T3
(es)
|
2006-03-24 |
2018-12-03 |
Handylab, Inc. |
Método para realizar PCR con un cartucho con varias pistas
|
US7998708B2
(en)
|
2006-03-24 |
2011-08-16 |
Handylab, Inc. |
Microfluidic system for amplifying and detecting polynucleotides in parallel
|
US11806718B2
(en)
|
2006-03-24 |
2023-11-07 |
Handylab, Inc. |
Fluorescence detector for microfluidic diagnostic system
|
US8883490B2
(en)
|
2006-03-24 |
2014-11-11 |
Handylab, Inc. |
Fluorescence detector for microfluidic diagnostic system
|
US8492097B2
(en)
|
2006-04-24 |
2013-07-23 |
Diagnostic Hybrids, Inc. |
Compositions and methods for human metapneumovirus monoclonal antibodies
|
AU2007255110B8
(en)
*
|
2006-06-02 |
2014-04-10 |
Pfizer Products Inc. |
Circulating tumor cell assay
|
WO2008028264A1
(en)
*
|
2006-09-05 |
2008-03-13 |
Centro Brasileiro De Pesquisas Fisicas-Cbpf |
Process for the production of micro-capsules having magnetic properties, product obtained therefrom and method for the controlled release of active substances
|
US20080300798A1
(en)
*
|
2007-04-16 |
2008-12-04 |
Mcdevitt John T |
Cardibioindex/cardibioscore and utility of salivary proteome in cardiovascular diagnostics
|
KR20150065903A
(ko)
|
2007-06-05 |
2015-06-15 |
뱅크 오브 캐나다 |
잉크 또는 토너 조성물, 사용 방법 및 이로부터 유래된 제품
|
AU2008276211B2
(en)
|
2007-07-13 |
2015-01-22 |
Handylab, Inc. |
Polynucleotide capture materials, and methods of using same
|
US8182763B2
(en)
|
2007-07-13 |
2012-05-22 |
Handylab, Inc. |
Rack for sample tubes and reagent holders
|
US8105783B2
(en)
|
2007-07-13 |
2012-01-31 |
Handylab, Inc. |
Microfluidic cartridge
|
US8287820B2
(en)
|
2007-07-13 |
2012-10-16 |
Handylab, Inc. |
Automated pipetting apparatus having a combined liquid pump and pipette head system
|
US9186677B2
(en)
|
2007-07-13 |
2015-11-17 |
Handylab, Inc. |
Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples
|
WO2009033056A1
(en)
*
|
2007-09-06 |
2009-03-12 |
Bioscale, Inc. |
Reusable detection surfaces and methods of using same
|
EP3338895B1
(de)
|
2007-12-07 |
2022-08-10 |
Miltenyi Biotec B.V. & Co. KG |
Probenverarbeitungssysteme und -verfahren
|
US20110275985A1
(en)
*
|
2008-07-03 |
2011-11-10 |
T2 Biosystems, Inc. |
Magnetic nanosensor compositions and bioanalytical assays therefor
|
WO2011109440A1
(en)
|
2010-03-01 |
2011-09-09 |
Caris Life Sciences Luxembourg Holdings |
Biomarkers for theranostics
|
EP2730662A1
(de)
|
2008-11-12 |
2014-05-14 |
Caris Life Sciences Luxembourg Holdings |
Verfahren und Systeme zur Verwendung von Exosomen zur Bestimmung von Phänotypen
|
US8710836B2
(en)
*
|
2008-12-10 |
2014-04-29 |
Nanomr, Inc. |
NMR, instrumentation, and flow meter/controller continuously detecting MR signals, from continuously flowing sample material
|
EP2230515B1
(de)
|
2009-03-16 |
2014-12-17 |
Agilent Technologies, Inc. |
Passivierung von Oberflächen nach Ligandenkupplung
|
US8790916B2
(en)
*
|
2009-05-14 |
2014-07-29 |
Genestream, Inc. |
Microfluidic method and system for isolating particles from biological fluid
|
JP5270486B2
(ja)
*
|
2009-07-31 |
2013-08-21 |
トヨタ自動車株式会社 |
ナノ物質集積体の製造方法、ナノ物質集積体およびそれを用いたデバイス、ならびにナノ物質の構造解析方法
|
US20140148348A1
(en)
|
2010-01-13 |
2014-05-29 |
Christine Kuslich |
Dectection of gastrointestinal disorders
|
EP2556172A4
(de)
|
2010-04-06 |
2013-10-30 |
Caris Life Sciences Luxembourg Holdings |
Zirkulierende biomarker für krankheiten
|
US8841104B2
(en)
|
2010-04-21 |
2014-09-23 |
Nanomr, Inc. |
Methods for isolating a target analyte from a heterogeneous sample
|
US9428547B2
(en)
|
2010-04-21 |
2016-08-30 |
Dna Electronics, Inc. |
Compositions for isolating a target analyte from a heterogeneous sample
|
US20110262989A1
(en)
|
2010-04-21 |
2011-10-27 |
Nanomr, Inc. |
Isolating a target analyte from a body fluid
|
US9476812B2
(en)
|
2010-04-21 |
2016-10-25 |
Dna Electronics, Inc. |
Methods for isolating a target analyte from a heterogeneous sample
|
CN103154740B
(zh)
|
2010-10-14 |
2016-08-03 |
维里德克斯有限责任公司 |
使用多特异性捕获和混合物检测试剂检测胰腺患者中的循环肿瘤细胞的方法和试剂盒
|
ES2769028T3
(es)
|
2011-04-15 |
2020-06-24 |
Becton Dickinson Co |
Termociclador microfluídico de barrido en tiempo real
|
DE102011050550A1
(de)
*
|
2011-05-20 |
2012-11-22 |
Wolfgang Göhde |
Verfahren und Anordnung zur Quantifizierung von Untergruppen aus einer Mischpopulation von Zellen
|
WO2013006774A1
(en)
|
2011-07-07 |
2013-01-10 |
Veridex, Llc |
Genomic diagnostics using circulating endothelial cells
|
US20130095038A1
(en)
*
|
2011-10-15 |
2013-04-18 |
Canon Kabushiki Kaisha |
Particles, and photoacoustic imaging contrast agent and sln contrast agent including the particles
|
CN104040238B
(zh)
|
2011-11-04 |
2017-06-27 |
汉迪拉布公司 |
多核苷酸样品制备装置
|
JP6301263B2
(ja)
|
2011-12-23 |
2018-03-28 |
デピュイ・シンセス・プロダクツ・インコーポレイテッド |
ヒト臍帯組織由来細胞の検出
|
WO2013106948A1
(zh)
|
2012-01-18 |
2013-07-25 |
芮宝生医股份有限公司 |
磁性微粒复合物的制作方法
|
CA2928520C
(en)
|
2012-10-23 |
2023-03-14 |
Caris Life Sciences Switzerland Holdings, S.A.R.L. |
Aptamers and uses thereof
|
US10942184B2
(en)
|
2012-10-23 |
2021-03-09 |
Caris Science, Inc. |
Aptamers and uses thereof
|
US10000557B2
(en)
|
2012-12-19 |
2018-06-19 |
Dnae Group Holdings Limited |
Methods for raising antibodies
|
US9434940B2
(en)
|
2012-12-19 |
2016-09-06 |
Dna Electronics, Inc. |
Methods for universal target capture
|
US9599610B2
(en)
|
2012-12-19 |
2017-03-21 |
Dnae Group Holdings Limited |
Target capture system
|
US9804069B2
(en)
|
2012-12-19 |
2017-10-31 |
Dnae Group Holdings Limited |
Methods for degrading nucleic acid
|
US9995742B2
(en)
|
2012-12-19 |
2018-06-12 |
Dnae Group Holdings Limited |
Sample entry
|
CA2895847C
(en)
|
2012-12-19 |
2019-01-08 |
Caris Science, Inc. |
Compositions and methods for aptamer screening
|
US9551704B2
(en)
|
2012-12-19 |
2017-01-24 |
Dna Electronics, Inc. |
Target detection
|
RU2507155C1
(ru)
*
|
2012-12-28 |
2014-02-20 |
Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Национальный исследовательский технологический университет "МИСиС" |
Способ получения наночастиц магнетита, стабилизированных поливиниловым спиртом
|
AU2014312211A1
(en)
|
2013-08-28 |
2016-03-10 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
WO2015128725A1
(en)
*
|
2014-02-28 |
2015-09-03 |
Dh Technologies Development Pte. Ltd. |
Magnetic elements for processing fluids
|
WO2015164675A1
(en)
|
2014-04-23 |
2015-10-29 |
Juno Therapeutics, Inc. |
Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
|
MA40253A
(fr)
|
2014-07-15 |
2017-05-24 |
Juno Therapeutics Inc |
Cellules modifiées pour thérapie cellulaire adoptive
|
TWI751102B
(zh)
|
2014-08-28 |
2022-01-01 |
美商奇諾治療有限公司 |
對cd19具專一性之抗體及嵌合抗原受體
|
IL293714A
(en)
|
2014-10-20 |
2022-08-01 |
Juno Therapeutics Inc |
Methods and preparations for dosing in stress cell therapy
|
TWI787903B
(zh)
|
2014-11-05 |
2022-12-21 |
美商奇諾治療有限公司 |
用於轉導作用及細胞處理之方法
|
JP7068820B2
(ja)
|
2014-12-03 |
2022-05-17 |
ジュノー セラピューティクス インコーポレイテッド |
養子細胞療法のための方法および組成物
|
MA41346A
(fr)
|
2015-01-12 |
2017-11-21 |
Juno Therapeutics Inc |
Eléments régulateurs post-transcriptionnels d'hépatite modifiée
|
AR103442A1
(es)
|
2015-01-16 |
2017-05-10 |
Juno Therapeutics Inc |
Anticuerpos y receptores de antígenos quiméricos específicos de ror1
|
DE102015101834A1
(de)
|
2015-02-09 |
2016-08-11 |
Technische Universität Ilmenau |
Verfahren und Vorrichtung zur Detektion und Lokalisierung von mikrostimulierten Partikeln
|
WO2016145128A1
(en)
|
2015-03-09 |
2016-09-15 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
WO2016166568A1
(en)
|
2015-04-16 |
2016-10-20 |
Juno Therapeutics Gmbh |
Methods, kits and apparatus for expanding a population of cells
|
WO2016179053A1
(en)
|
2015-05-01 |
2016-11-10 |
BioLegend, Inc. |
Stable nanomagnetic particle dispersions
|
MA43344A
(fr)
|
2015-05-29 |
2018-04-11 |
Juno Therapeutics Inc |
Composition et procédés de régulation des interactions inhibitrices dans les cellules génétiquement modifiées
|
CA2991045A1
(en)
|
2015-06-29 |
2017-01-05 |
Caris Science, Inc. |
Therapeutic oligonucleotides binding c1q
|
MA42895A
(fr)
|
2015-07-15 |
2018-05-23 |
Juno Therapeutics Inc |
Cellules modifiées pour thérapie cellulaire adoptive
|
WO2017019918A1
(en)
|
2015-07-28 |
2017-02-02 |
Caris Science, Inc. |
Targeted oligonucleotides
|
US20180251810A1
(en)
|
2015-09-11 |
2018-09-06 |
Bacteria Detection Ltd |
Methods for isolating microbial cells from a blood sample
|
MA45488A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés, kits et appareil de culture de cellules
|
MA45489A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés de culture de cellules, kits et appareil associés
|
WO2017068419A2
(en)
|
2015-10-22 |
2017-04-27 |
Juno Therapeutics Gmbh |
Methods, kits, agents and apparatuses for transduction
|
US11020429B2
(en)
|
2015-11-05 |
2021-06-01 |
Juno Therapeutics, Inc. |
Vectors and genetically engineered immune cells expressing metabolic pathway modulators and uses in adoptive cell therapy
|
MA44314A
(fr)
|
2015-11-05 |
2018-09-12 |
Juno Therapeutics Inc |
Récepteurs chimériques contenant des domaines induisant traf, et compositions et méthodes associées
|
ES2928167T3
(es)
|
2015-12-03 |
2022-11-15 |
Juno Therapeutics Inc |
Composiciones y métodos para reducir las respuestas inmunitarias contra receptores de antígenos quiméricos
|
AU2016363025B2
(en)
|
2015-12-03 |
2021-04-08 |
Juno Therapeutics, Inc. |
Modified chimeric receptors and related compositions and methods
|
EP4012415A3
(de)
|
2015-12-04 |
2022-12-07 |
Juno Therapeutics, Inc. |
Verfahren und zusammensetzungen in zusammenhang mit zelltherapieassoziierter toxizität
|
JP7114477B2
(ja)
|
2015-12-16 |
2022-08-08 |
グリットストーン バイオ インコーポレイテッド |
新生抗原の特定、製造、および使用
|
US20190355459A1
(en)
|
2016-03-16 |
2019-11-21 |
Juno Therapeutics, Inc. |
Methods for adaptive design of a treatment regimen and related treatments
|
MA43758A
(fr)
|
2016-03-16 |
2018-11-28 |
Yuan Ji |
Procédés pour déterminer le dosage d'un agent thérapeutique et traitements associés
|
KR20190008843A
(ko)
|
2016-03-18 |
2019-01-25 |
카리스 싸이언스, 인코포레이티드 |
올리고뉴클레오티드 프로브 및 이의 용도
|
ES2907557T3
(es)
|
2016-03-22 |
2022-04-25 |
Seattle Childrens Hospital Dba Seattle Childrens Res Inst |
Métodos de intervención temprana para prevenir o mejorar la toxicidad
|
EP4134427A1
(de)
|
2016-04-30 |
2023-02-15 |
Biolegend, Inc. |
Zusammensetzungen und verfahren zur durchführung von magnetisboyanttrennungen
|
US11293017B2
(en)
|
2016-05-25 |
2022-04-05 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
EP4011381A1
(de)
|
2016-06-03 |
2022-06-15 |
Memorial Sloan-Kettering Cancer Center |
Adoptive zelltherapien als frühe behandlungsoptionen
|
MA45341A
(fr)
|
2016-06-06 |
2019-04-10 |
Hutchinson Fred Cancer Res |
Procédés de traitement de malignités de lymphocytes b au moyen d'une thérapie cellulaire adoptive
|
CN110291402B
(zh)
|
2016-06-27 |
2023-09-01 |
朱诺治疗学股份有限公司 |
鉴定肽表位的方法、结合此类表位的分子和相关用途
|
MA45491A
(fr)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics Inc |
Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
|
MA45784A
(fr)
|
2016-07-29 |
2019-06-05 |
Juno Therapeutics Inc |
Anticorps anti-idiotypes dirigés contre anti-cd19 anticorps
|
MA45779A
(fr)
|
2016-07-29 |
2019-06-05 |
Juno Therapeutics Inc |
Polypeptides immunomdulateurs et compositions et procédés associés
|
CN109804089A
(zh)
|
2016-07-29 |
2019-05-24 |
朱诺治疗学股份有限公司 |
用于评估复制型病毒存在或不存在的方法
|
CA3033911A1
(en)
|
2016-08-26 |
2018-03-01 |
Juno Therapeutics, Inc. |
Methods of enumerating particles present in a cell composition
|
US20190211292A1
(en)
|
2016-09-12 |
2019-07-11 |
Juno Therapeutics, Inc. |
Perfusion bioreactor bag assemblies
|
WO2018067618A1
(en)
|
2016-10-03 |
2018-04-12 |
Juno Therapeutics, Inc. |
Hpv-specific binding molecules
|
AU2017343780B2
(en)
|
2016-10-13 |
2023-08-31 |
Juno Therapeutics, Inc. |
Immunotherapy methods and compositions involving tryptophan metabolic pathway modulators
|
MA46716A
(fr)
|
2016-11-03 |
2019-09-11 |
Juno Therapeutics Inc |
Polythérapie de thérapie cellulaire et d'inhibiteur de la microglie
|
MX2019005029A
(es)
|
2016-11-03 |
2019-10-24 |
Juno Therapeutics Inc |
Terapia de combinación de una terapia de células t y un inhibidor de tirosina cinasa de bruton (btk).
|
US11793833B2
(en)
|
2016-12-02 |
2023-10-24 |
Juno Therapeutics, Inc. |
Engineered B cells and related compositions and methods
|
CN110248678A
(zh)
|
2016-12-03 |
2019-09-17 |
朱诺治疗学股份有限公司 |
调节car-t细胞的方法
|
US11590167B2
(en)
|
2016-12-03 |
2023-02-28 |
Juno Therapeutic, Inc. |
Methods and compositions for use of therapeutic T cells in combination with kinase inhibitors
|
AU2017368333A1
(en)
|
2016-12-03 |
2019-06-13 |
Juno Therapeutics, Inc. |
Methods for determining CAR-T cells dosing
|
WO2018106732A1
(en)
|
2016-12-05 |
2018-06-14 |
Juno Therapeutics, Inc. |
Production of engineered cells for adoptive cell therapy
|
WO2018132518A1
(en)
|
2017-01-10 |
2018-07-19 |
Juno Therapeutics, Inc. |
Epigenetic analysis of cell therapy and related methods
|
EP3571221A2
(de)
|
2017-01-20 |
2019-11-27 |
Juno Therapeutics GmbH |
Zelloberflächenkonjugate und verwandte zellzusammensetzungen und verfahren
|
CN110461335A
(zh)
|
2017-02-17 |
2019-11-15 |
弗雷德哈钦森癌症研究中心 |
用于治疗bcma相关癌症和自身免疫性失调的联合疗法
|
EP4353818A2
(de)
|
2017-02-27 |
2024-04-17 |
Juno Therapeutics, Inc. |
Zusammensetzungen, hergestellte artikel und verfahren im zusammenhang mit der dosierung in der zelltherapie
|
WO2018170188A2
(en)
|
2017-03-14 |
2018-09-20 |
Juno Therapeutics, Inc. |
Methods for cryogenic storage
|
JP7284707B2
(ja)
|
2017-04-07 |
2023-05-31 |
ジュノー セラピューティクス インコーポレイテッド |
前立腺特異的膜抗原(psma)またはその改変型を発現する操作された細胞および関連方法
|
AU2018251188A1
(en)
|
2017-04-14 |
2019-10-31 |
Juno Therapeutics, Inc. |
Methods for assessing cell surface glycosylation
|
WO2018197949A1
(en)
|
2017-04-27 |
2018-11-01 |
Juno Therapeutics Gmbh |
Oligomeric particle reagents and methods of use thereof
|
JP7299841B2
(ja)
|
2017-05-01 |
2023-06-28 |
ジュノー セラピューティクス インコーポレイテッド |
細胞療法と免疫調節化合物の併用
|
MA48781A
(fr)
|
2017-06-02 |
2020-04-08 |
Juno Therapeutics Inc |
Articles de fabrication et procédés liés à la toxicité associée à la thérapie cellulaire
|
BR112019025403A2
(pt)
|
2017-06-02 |
2020-08-18 |
Juno Therapeutics Inc |
artigos de fabricação e métodos para tratamento usando terapia celular adotiva
|
JP2020526194A
(ja)
|
2017-06-29 |
2020-08-31 |
ジュノー セラピューティクス インコーポレイテッド |
免疫療法薬と関連する毒性を評価するためのマウスモデル
|
SG11202000606TA
(en)
|
2017-07-29 |
2020-02-27 |
Juno Therapeutics Inc |
Reagents for expanding cells expressing recombinant receptors
|
KR20200054178A
(ko)
|
2017-08-09 |
2020-05-19 |
주노 쎄러퓨티크스 인코퍼레이티드 |
유전자 조작된 세포 조성물 및 관련 조성물의 제조 방법
|
US20200239910A1
(en)
|
2017-08-09 |
2020-07-30 |
Juno Therapeutics, Inc. |
Methods and compositions for preparing genetically engineered cells
|
US20210071258A1
(en)
|
2017-09-01 |
2021-03-11 |
Juno Therapeutics, Inc. |
Gene expression and assessment of risk of developing toxicity following cell therapy
|
MA50079A
(fr)
|
2017-09-07 |
2020-07-15 |
Juno Therapeutics Inc |
Procédés d'identification de caractéristiques cellulaires relatives à des réponses associées à une thérapie cellulaire
|
KR20200104284A
(ko)
|
2017-10-03 |
2020-09-03 |
주노 쎄러퓨티크스 인코퍼레이티드 |
Hpv-특이적 결합 분자
|
AU2018348165A1
(en)
|
2017-10-10 |
2020-05-21 |
Gritstone Bio, Inc. |
Neoantigen identification using hotspots
|
CN111542596A
(zh)
|
2017-11-01 |
2020-08-14 |
朱诺治疗学股份有限公司 |
产生工程化细胞的治疗性组合物的方法
|
US20210132042A1
(en)
|
2017-11-01 |
2021-05-06 |
Juno Therapeutics, Inc. |
Methods of assessing or monitoring a response to a cell therapy
|
MX2020004239A
(es)
|
2017-11-01 |
2020-09-09 |
Juno Therapeutics Inc |
Proceso para producir una composicion de celulas t.
|
US11564946B2
(en)
|
2017-11-01 |
2023-01-31 |
Juno Therapeutics, Inc. |
Methods associated with tumor burden for assessing response to a cell therapy
|
BR112020008323A2
(pt)
|
2017-11-01 |
2020-11-03 |
Juno Therapeutics Inc |
anticorpos e receptores de antígenos quiméricos específicos para antígeno de maturação de células b
|
KR20200116077A
(ko)
|
2017-11-01 |
2020-10-08 |
주노 쎄러퓨티크스 인코퍼레이티드 |
B 세포 성숙 항원에 특이적인 키메라 항원 수용체 및 암호화 폴리뉴클레오타이드
|
US20200289565A1
(en)
|
2017-11-06 |
2020-09-17 |
Juno Therapeutics, Inc. |
Combination of a cell therapy and a gamma secretase inhibitor
|
MA50571A
(fr)
|
2017-11-10 |
2020-09-16 |
Juno Therapeutics Inc |
Réservoirs cryogéniques à système fermé
|
AU2018373154A1
(en)
|
2017-11-22 |
2020-07-02 |
Gritstone Bio, Inc. |
Reducing junction epitope presentation for neoantigens
|
EP3716980A1
(de)
|
2017-12-01 |
2020-10-07 |
Juno Therapeutics, Inc. |
Verfahren zur dosieren und modulierung von genetisch veränderten zellen
|
US20210207080A1
(en)
|
2017-12-08 |
2021-07-08 |
Juno Therapeutics, Inc. |
Serum-free media formulation for culturing cells and methods of use thereof
|
SG11202005272SA
(en)
|
2017-12-08 |
2020-07-29 |
Juno Therapeutics Inc |
Process for producing a composition of engineered t cells
|
SG11202005217VA
(en)
|
2017-12-08 |
2020-07-29 |
Juno Therapeutics Inc |
Phenotypic markers for cell therapy and related methods
|
WO2019118937A1
(en)
|
2017-12-15 |
2019-06-20 |
Juno Therapeutics, Inc. |
Anti-cct5 binding molecules and methods of use thereof
|
CN111918972A
(zh)
|
2018-01-31 |
2020-11-10 |
朱诺治疗学股份有限公司 |
评估存在或不存在有复制能力的病毒的方法和试剂
|
JP7383620B2
(ja)
|
2018-01-31 |
2023-11-20 |
セルジーン コーポレイション |
養子細胞療法およびチェックポイント阻害剤を使用する併用療法
|
WO2019169194A1
(en)
|
2018-02-28 |
2019-09-06 |
Juno Therapeutics, Inc. |
Methods for detecting particles present in a cell composition
|
EP3762012A1
(de)
|
2018-03-09 |
2021-01-13 |
Ospedale San Raffaele S.r.l. |
Il-1-antagonist und durch zelltherapie induzierte toxizität
|
MA52207A
(fr)
|
2018-04-05 |
2021-02-17 |
Editas Medicine Inc |
Lymphocytes t exprimant un récepteur recombinant, polynucléotides et procédés associés
|
US11471489B2
(en)
|
2018-04-05 |
2022-10-18 |
Juno Therapeutics, Inc. |
T cell receptors and engineered cells expressing same
|
CA3094468A1
(en)
|
2018-04-05 |
2019-10-10 |
Juno Therapeutics, Inc. |
Methods of producing cells expressing a recombinant receptor and related compositions
|
AU2019261986A1
(en)
|
2018-05-03 |
2020-11-26 |
Juno Therapeutics, Inc. |
Combination therapy of a chimeric antigen receptor (CAR) T cell therapy and a kinase inhibitor
|
EP3790832A4
(de)
|
2018-05-08 |
2021-05-05 |
Biomagnetic Solutions LLC |
Starre kammer zur zelltrennung aus einem flexiblen einwegbeutel
|
JP2021528101A
(ja)
|
2018-06-13 |
2021-10-21 |
アクロン バイオテクノロジー,エルエルシー. |
液体医薬組成物中で非常に安定な治療的に活性なアルデスロイキンを調製する方法
|
KR20210059715A
(ko)
|
2018-08-09 |
2021-05-25 |
주노 쎄러퓨티크스 인코퍼레이티드 |
통합된 핵산 평가 방법
|
JP2021533746A
(ja)
|
2018-08-09 |
2021-12-09 |
ジュノー セラピューティクス インコーポレイテッド |
操作された細胞およびその組成物を生成するための方法
|
BR112021003757A2
(pt)
|
2018-08-31 |
2021-05-25 |
Invectys SA |
receptores de antígenos quiméricos contra múltiplas isoformas de hla-g
|
BR112021004261A2
(pt)
|
2018-09-11 |
2021-05-25 |
Juno Therapeutics Inc |
métodos para análise por espectrometria de massas de composições de células geneticamente modificadas
|
JP2022506598A
(ja)
|
2018-11-01 |
2022-01-17 |
ジュノー セラピューティクス インコーポレイテッド |
Gタンパク質共役受容体クラスcグループ5メンバーd(gprc5d)に特異的なキメラ抗原受容体
|
JP2022512917A
(ja)
|
2018-11-01 |
2022-02-07 |
ジュノー セラピューティクス インコーポレイテッド |
B細胞成熟抗原に特異的なキメラ抗原受容体を使用する処置方法
|
CN113272018A
(zh)
|
2018-11-06 |
2021-08-17 |
朱诺治疗学股份有限公司 |
产生基因工程化t细胞的方法
|
CA3117978A1
(en)
|
2018-11-08 |
2020-05-14 |
Juno Therapeutics, Inc. |
Methods and combinations for treatment and t cell modulation
|
KR20210104713A
(ko)
|
2018-11-16 |
2021-08-25 |
주노 쎄러퓨티크스 인코퍼레이티드 |
B 세포 악성 종양 치료를 위한 조작된 t 세포 투약 방법
|
KR20210117260A
(ko)
|
2018-11-30 |
2021-09-28 |
주노 쎄러퓨티크스 인코퍼레이티드 |
입양 세포 요법을 사용한 치료방법
|
US20220031746A1
(en)
|
2018-11-30 |
2022-02-03 |
Juno Therapeutics, Inc. |
Methods for dosing and treatment of b cell malignancies in adoptive cell therapy
|
MA54863A
(fr)
|
2019-01-29 |
2021-12-08 |
Juno Therapeutics Inc |
Anticorps et récepteurs antigéniques chimériques spécifiques du récepteur orphelin-1 de type récepteur à tyrosine kinase (ror1)
|
CA3136742A1
(en)
|
2019-05-01 |
2020-11-05 |
Juno Therapeutics, Inc. |
Cells expressing a chimeric receptor from a modified cd247 locus, related polynucleotides and methods
|
SG11202111360YA
(en)
|
2019-05-01 |
2021-11-29 |
Juno Therapeutics Inc |
Cells expressing a recombinant receptor from a modified tgfbr2 locus, related polynucleotides and methods
|
EP3983006A1
(de)
|
2019-06-12 |
2022-04-20 |
Juno Therapeutics, Inc. |
Kombinationstherapie aus einer zellvermittelten zytotoxischen therapie und einem inhibitor eines prosurvival-bcl2--familienproteins
|
WO2021035194A1
(en)
|
2019-08-22 |
2021-02-25 |
Juno Therapeutics, Inc. |
Combination therapy of a t cell therapy and an enhancer of zeste homolog 2 (ezh2) inhibitor and related methods
|
WO2021041994A2
(en)
|
2019-08-30 |
2021-03-04 |
Juno Therapeutics, Inc. |
Machine learning methods for classifying cells
|
EP4055383A1
(de)
|
2019-11-05 |
2022-09-14 |
Juno Therapeutics, Inc. |
Verfahren zur bestimmung von eigenschaften therapeutischer t-zellzusammensetzungen
|
EP4054623A1
(de)
|
2019-11-07 |
2022-09-14 |
Juno Therapeutics, Inc. |
Kombination aus einer t-zelltherapie und (s)-3-[4-(4-morpholin-4 ylmethyl-benzyloxy)-l-oxo-l,3-dihydro-isoindol-2-yl]-piperidin-2,6-dion
|
JP2023504740A
(ja)
|
2019-12-06 |
2023-02-06 |
ジュノー セラピューティクス インコーポレイテッド |
Bcma標的結合ドメインに対する抗イディオタイプ抗体ならびに関連する組成物および方法
|
CN115398231A
(zh)
|
2019-12-06 |
2022-11-25 |
朱诺治疗学股份有限公司 |
与治疗b细胞恶性肿瘤的细胞疗法相关的毒性和反应的相关方法
|
WO2021113780A1
(en)
|
2019-12-06 |
2021-06-10 |
Juno Therapeutics, Inc. |
Anti-idiotypic antibodies to gprc5d-targeted binding domains and related compositions and methods
|
MX2022009041A
(es)
|
2020-01-24 |
2022-10-07 |
Juno Therapeutics Inc |
Metodos de dosificacion y tratamiento de linfoma folicular y linfoma de zona marginal en terapia celular adoptiva.
|
JP2023512209A
(ja)
|
2020-01-28 |
2023-03-24 |
ジュノー セラピューティクス インコーポレイテッド |
T細胞形質導入のための方法
|
US20230087953A1
(en)
|
2020-02-12 |
2023-03-23 |
Juno Therapeutics, Inc. |
Bcma-directed chimeric antigen receptor t cell compositions and methods and uses thereof
|
EP4103204A1
(de)
|
2020-02-12 |
2022-12-21 |
Juno Therapeutics, Inc. |
Cd19-gerichtete chimäre antigen-rezeptor-t-zell-zusammensetzungen und verfahren und verwendungen davon
|
WO2021207689A2
(en)
|
2020-04-10 |
2021-10-14 |
Juno Therapeutics, Inc. |
Methods and uses related to cell therapy engineered with a chimeric antigen receptor targeting b-cell maturation antigen
|
WO2021222330A2
(en)
|
2020-04-28 |
2021-11-04 |
Juno Therapeutics, Inc. |
Combination of bcma-directed t cell therapy and an immunomodulatory compound
|
EP4150057A2
(de)
|
2020-05-13 |
2023-03-22 |
Juno Therapeutics, Inc. |
Verfahren zur herstellung von donor-batch zellen, die einen rekombinanten rezeptor exprimieren
|
WO2021231657A1
(en)
|
2020-05-13 |
2021-11-18 |
Juno Therapeutics, Inc. |
Methods of identifying features associated with clinical response and uses thereof
|
CN116234558A
(zh)
|
2020-06-26 |
2023-06-06 |
朱诺治疗学有限公司 |
条件性地表达重组受体的工程化t细胞、相关多核苷酸和方法
|
WO2022029660A1
(en)
|
2020-08-05 |
2022-02-10 |
Juno Therapeutics, Inc. |
Anti-idiotypic antibodies to ror1-targeted binding domains and related compositions and methods
|
EP4240756A1
(de)
|
2020-11-04 |
2023-09-13 |
Juno Therapeutics, Inc. |
Zellen zur expression eines chimären rezeptors aus einem modifizierten invarianten kettenlocus der cd3-immunglobulin-superfamilie und zugehörige polynukleotide und verfahren
|
WO2022133030A1
(en)
|
2020-12-16 |
2022-06-23 |
Juno Therapeutics, Inc. |
Combination therapy of a cell therapy and a bcl2 inhibitor
|
JP2024509853A
(ja)
|
2021-03-03 |
2024-03-05 |
ジュノー セラピューティクス インコーポレイテッド |
T細胞療法およびdgk阻害剤の組合せ
|
AU2022241654A1
(en)
|
2021-03-22 |
2023-09-28 |
Juno Therapeutics, Inc. |
Methods of determining potency of a therapeutic cell composition
|
IL307257A
(en)
|
2021-03-29 |
2023-11-01 |
Juno Therapeutics Inc |
A combination of car cell therapy and an immunomodulatory compound for the treatment of lymphoma
|
IL307262A
(en)
|
2021-03-29 |
2023-11-01 |
Juno Therapeutics Inc |
METHODS FOR DOSAGE AND THERAPY IN COMBINATION OF CHECKPOINT INHIBITOR AND CAR T CELL THERAPY
|
JP2024514163A
(ja)
|
2021-04-16 |
2024-03-28 |
セルジーン コーポレーション |
Bcma指向性t細胞療法を用いた併用療法
|
CN113281500B
(zh)
*
|
2021-05-21 |
2022-07-12 |
深圳市光与生物科技有限公司 |
一种用于单分子检测的磁珠及其制备方法
|
WO2023081735A1
(en)
|
2021-11-03 |
2023-05-11 |
Celgene Corporation |
Chimeric antigen receptors specific for b-cell maturation antigen for use in treating myeloma
|
WO2023081900A1
(en)
|
2021-11-08 |
2023-05-11 |
Juno Therapeutics, Inc. |
Engineered t cells expressing a recombinant t cell receptor (tcr) and related systems and methods
|
WO2023147515A1
(en)
|
2022-01-28 |
2023-08-03 |
Juno Therapeutics, Inc. |
Methods of manufacturing cellular compositions
|
WO2023164440A1
(en)
|
2022-02-22 |
2023-08-31 |
Juno Therapeutics, Inc. |
Proteinase 3 (pr3) chimeric autoantibody receptor t cells and related methods and uses
|
WO2023220655A1
(en)
|
2022-05-11 |
2023-11-16 |
Celgene Corporation |
Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy
|
WO2023230581A1
(en)
|
2022-05-25 |
2023-11-30 |
Celgene Corporation |
Methods of manufacturing t cell therapies
|
WO2023230548A1
(en)
|
2022-05-25 |
2023-11-30 |
Celgene Corporation |
Method for predicting response to a t cell therapy
|
WO2023250400A1
(en)
|
2022-06-22 |
2023-12-28 |
Juno Therapeutics, Inc. |
Treatment methods for second line therapy of cd19-targeted car t cells
|
WO2024006960A1
(en)
|
2022-06-29 |
2024-01-04 |
Juno Therapeutics, Inc. |
Lipid nanoparticles for delivery of nucleic acids
|
US20240041929A1
(en)
|
2022-08-05 |
2024-02-08 |
Juno Therapeutics, Inc. |
Chimeric antigen receptors specific for gprc5d and bcma
|
WO2024044779A2
(en)
|
2022-08-26 |
2024-02-29 |
Juno Therapeutics, Inc. |
Antibodies and chimeric antigen receptors specific for delta-like ligand 3 (dll3)
|
WO2024054944A1
(en)
|
2022-09-08 |
2024-03-14 |
Juno Therapeutics, Inc. |
Combination of a t cell therapy and continuous or intermittent dgk inhibitor dosing
|